LGALS9 and pancreatic ductal adenocarcinoma: For example, exosomes loaded with miR-122 sensitize HCC cells to sorafenib [429], and those carrying galectin-9 siRNA enhance immunotherapy in pancreatic ductal adenocarcinoma [430].